VitaNova Life Sciences Corporation Liabilities Subject to Compromise, Debt and Accrued Interest
VitaNova Life Sciences Corporation (VNOV) had Liabilities Subject to Compromise, Debt and Accrued Interest of $0 as of 2020-01-31, per its 10-Q filed 2020-03-20.
Discontinued › Notes
us-gaap:LiabilitiesSubjectToCompromiseDebtAndAccruedInterest · last filed 2020-03-20
- 2020-01-31: Liabilities Subject to Compromise, Debt and Accrued Interest $0.00.
- 2019-10-31: Liabilities Subject to Compromise, Debt and Accrued Interest $0.00.
- 2019-07-31: Liabilities Subject to Compromise, Debt and Accrued Interest $0.00.
| Period end | Liabilities Subject to Compromise, Debt and Accrued Interest |
|---|---|
| 2020-01-31 | $0.00 10-Q · filed 2020-03-20 |
| 2019-10-31 | $0.00 10-Q · filed 2019-12-06 |
| 2019-07-31 | $0.00 10-Q · filed 2019-09-12 |